	销售和管理费用		日
Akebia Therapeutics	USD 23.53M	3.19M	2025-12
Alaunos Therapeutics	USD 585K	84K	2025-09
Avita Medical	AUD 19.03M	1.95M	2025-12
Celltrion	KRW 12.71B	237.27B	2025-12
Cspc Pharmaceutical	CNY 1.87B	95.62M	2025-12
Deva Holding AS	TRY 462.26M	48.18M	2023-09
Dianthus Therapeutics	USD 6.57M	1.62M	2025-12
Divis Laboratories Ltd	INR 3.4B	10M	2025-06
IQVIA Holdings	USD 502M	34M	2026-03
Kangmei Pharma	CNY 274.41M	15.05M	2025-09
Knight Therapeutics	CAD 35.45M	4.43M	2025-12
Laboratorios Farma	EUR 35.32M	2.75M	2025-06
Malin Corporation	EUR 1.1M	400K	2024-12
Medical Developments International	AUD 2.84M	4.19M	2025-12
Moderna	USD 173M	135M	2026-03
Neuren Pharmaceuticals	AUD 3.74M	2.5M	2025-12
Organigram Holdings	CAD 7.73M	1.13M	2025-12
Organon & Co	USD 433M	34M	2025-12
Ovoca Bio	EUR 632K	2.33M	2025-06
Pharma Mar	EUR 15.31M	2M	2026-03
Qiagen NV	USD 153.88M	10.77M	2025-12
Revvity	USD 253.88M	2.15M	2026-03
Sartorius	EUR 221.3M	500K	2026-03
Sino Biopharmaceutical	CNY 7.54B	2.23B	2025-06
Tectonic Therapeutic	USD 3.44M	1.52M	2025-12
Tilray	USD 24.85M	1.7M	2025-09
Viatris	USD 928.8M	101.9M	2026-03
Xeris Pharmaceuticals	USD 42.64M	3.82M	2025-12
Zealand Pharma A/S	91.81M	99.04M	2025-12
Zz Pientze Pharmaceu	CNY 214.31M	42.4M	2026-03